Naomi Ninagawa

Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan.

Icross Co., Ltd. offers contract research organization (CRO) services. It provides clinical trials of pharmaceuticals and medical devices and clinical research support. The company was founded on January 24, 2007 and is headquartered in Tokyo, Japan.

Part of I'rom Group Co., Ltd., Ethic Co., Ltd. engages in clinical trial services for medical institutions. The company is based in Tokyo, Japan. Ethic Co. was acquired by I'rom Group Co., Ltd. on June 01, 2017 for $1.01 million.

Yusuke Sato Accounting Office is a specialist tax consulting service with over 10 years of experience in international taxes. The private company is based in Nishi-ku, Saitama-shi, Japan, and can be contacted through phone or email during business hours from Monday to Friday. The Japanese company has worked with clients from various business formats and provides services such as tax return formulation, international tax service, total review service, and tax texture. The company also offers consulting services for management support, company establishment, organizational construction, and accounting.

Nihonkaisui Co., Ltd. is a holding company that engages in salt business. It produces and supplies salt and its by-products. The firm’s products encompass classic, rock, iodized, functional, sun-dried, special grade, table, roasted, and brine salt. It also processes and supplies artificial seawater used for breeding salt-water fishes and plants. The company was founded in October 1995 and is headquartered in Tokyo, Japan.

ICELLEAP Co., Ltd. is a holding company that engages in the operation and management of relaxation and esthetic salons. It offers massage services and supplies cosmetic products. The firm also deals with human resources, general affairs, information technology, sports, and staff consulting services. The company was founded on March 15, 1947 and is headquartered in Tokyo, Japan.

Part of JSR Corp., Beijing B & m Biotech Co., Ltd. is a company that provides medical services and tools. The company is based in Beijing, China.

Part of Unison Capital, Inc., I'rom Pharmaceutical Co., Ltd. is a pharmaceutical company based in Tokyo, Japan. I'rom Pharmaceutical Co. manufactures and markets pharmaceuticals. I'rom Pharmaceutical Co. was acquired by Kyowa Pharmaceutical Industry Co., Ltd., a SUB of Unison Capital, Inc. from I'rom Group Co., Ltd. on November 30, 2011 for $40.28 million.

LOTTE Co., Ltd. manufactures and markets sweets, confectioneries, and desserts such as chewing gums, chocolates, candies, biscuits, cookies, and ice cream. It also engages in the business of real estate operations, golf course operations, and hotel and restaurant management services. The company was founded by Kyuk-Ho Shin in June 1948 and is headquartered in Tokyo, Japan.

Nomura Asset Management Co., Ltd. (NAM) is the wholly-owned investment management subsidiary of Nomura Holdings, Inc. (TYO: 8604; NYSE: NMR) in Japan. Founded in 1959 as Nomura Securities Investment Trust Co., Ltd., the firm became Nomura Asset Management Co., Ltd. in 1997 when they merged with Nomura Investment Management Co., Ltd. Headquartered in Tokyo, NAM provides investment advisory services globally to a broad range of institutional investors as well as pooled investment vehicles, including private funds and Japanese investment trusts.

Nomura International (Hong Kong) Ltd. (Nomura International HK) is the brokerage subsidiary of Nomura Asia Pacific Holdings Co. Ltd., which is ultimately-owned by Nomura Holdings, Inc. (TYO: 8604) in Japan. Headquartered in Hong Kong, the firm’s global markets team offers research, sales and trading of global securities to a diverse range of clients globally, including institutional investors, financial institutions, corporates, financial sponsors and government entities. Nomura International HK operates a truly integrated, cross-asset platform which includes research, sales and trading in equities, currencies, rates and credit in cash and derivative products.

Nomura Securities Co., Ltd. (NSC) is a wholly-owned brokerage subsidiary of Nomura Holdings, Inc. (TSE: 8604; NYSE: NMR). Headquartered in Tokyo, the firm was founded in 1925. NSC places a strong emphasis on research, both fundamental and quantitative. In addition to stock and bond underwriting, their activities include IPO and M&A advisory, wealth management, separately managed accounts, fund wrap services, prime brokerage and structured equity finance. Their clients include institutions, hedge funds, private banks and private equity funds as well as corporate clients and retail investors.